08:31 EDT Eli Lilly (LLY) to acquire Adverum Biotechnologies (ADVM) for up to $12.47 per share
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly, Incyte report results from BRAVE-AA-PEDS trial
- Eli Lilly reports findings from ADjoin extension trial of Ebglyss
- Eli Lilly’s New Phase 3 Study: A Potential Game-Changer for Alcohol Use Disorder
- Eli Lilly’s New Study on Brenipatide: A Potential Game-Changer for Alcohol Use Disorder
- Trump Trade: Trump administration prepares new probe into pharma prices